ALNA
Price:
$0.075
Market Cap:
$0
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2017-11-02
Stock Exchange
NASDAQ
Ticker
ALNA
According to Allena Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.11. This represents a change of -24.49% compared to the average of 2.79 of the last 4 quarters.
The mean historical Current Ratio of Allena Pharmaceuticals, Inc. over the last ten years is 9.13. The current 2.11 Current Ratio has changed 2.21% with respect to the historical average. Over the past ten years (40 quarters), ALNA's Current Ratio was at its highest in in the June 2018 quarter at 29.27. The Current Ratio was at its lowest in in the September 2016 quarter at 0.
Average
9.13
Median
11.19
Minimum
2.11
Maximum
15.16
Discovering the peaks and valleys of Allena Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 100.91%
Maximum Annual Current Ratio = 15.16
Minimum Annual Increase = -72.93%
Minimum Annual Current Ratio = 2.11
Year | Current Ratio | Change |
---|---|---|
2021 | 2.11 | -65.40% |
2020 | 6.08 | 100.91% |
2019 | 3.03 | -72.93% |
2018 | 11.19 | -12.13% |
2017 | 12.73 | -16.03% |
2016 | 15.16 | 11.51% |
The current Current Ratio of Allena Pharmaceuticals, Inc. (ALNA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.74
5-year avg
7.03
10-year avg
9.13
Allena Pharmaceuticals, Inc.’s Current Ratio is
Company | Current Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Allena Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Allena Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Allena Pharmaceuticals, Inc.'s Current Ratio?
How is the Current Ratio calculated for Allena Pharmaceuticals, Inc. (ALNA)?
What is the highest Current Ratio for Allena Pharmaceuticals, Inc. (ALNA)?
What is the 3-year average Current Ratio for Allena Pharmaceuticals, Inc. (ALNA)?
What is the 5-year average Current Ratio for Allena Pharmaceuticals, Inc. (ALNA)?
How does the current Current Ratio for Allena Pharmaceuticals, Inc. (ALNA) compare to its historical average?